“The market study analyzes offers an overview of the Sepsis Diagnostics market. It is a detailed assessment of the most important market dynamics and changing trends in the industry. After carrying out systematic research of cancer Sepsis Diagnostics, the business prospects for growth are obtained with extreme precision, along with historical as well as current development parameters. The study classifies the significant factors affecting the market throughout the forecast period. It can facilitate manufacturers to modify their production and marketing strategies in order to achieve growth.
Roche Diagnostics 9115 P 50457 450-045 SA Tel.7-51-000 1-31 Updates wrmoo ag1 TP-00495 V3. Firmware Updates — Accu-Chek ® Inform II Blood Glucose System, CoaguChek ® XS Pro System, and CoaguChek XS Plus System. Updates were made to pages 12, 13 and 25 of this Software Bulletin. Changes are marked by black bars. Roche Diagnostics source for product informtation including technical documentation, safety data sheets (SDS/MSDS), VENTANA product documents, package inserts, and links to Cell Marque product documentation.
The newest study on the Sepsis Diagnostics Market contains a comprehensive analysis of this industry and includes information about many industry segmentations. According to the study, the industry is presumed to gather significant revenue by the end of the estimated period while growing at a decent growth rate.
Get a Sample Copy of This Report @ https://www.quincemarketinsights.com/request-sample-59320?utm_source=tdc/ly
Impact of COVID-19 on the Market
The outbreak of COVID-19 has brought about many changes like travel bans, flight cancellations, quarantines, restrictions on all outdoor events, restaurants being closed, declaration of emergency in many countries, stock market unpredictability, massive disruptions in the supply chain, falling business growth, uncertainty about future, and growing panic among the population.
COVID-19 can affect the global economy by creating supply chain and market disturbances, by directly affecting production and demand, and by its economic effect on companies and commercial markets. The global Sepsis Diagnostics Market is also expected to be majorly affected by this global pandemic.
Major Points of the Study
Market :
Details concerning the industry size, remuneration potential, and volume share are compiled in this exhaustive market study. It further lists out the challenges and drivers that will influence the growth of the Sepsis Diagnostics Market throughout the projected time. The study also includes pricing and reimbursement structure, regulatory structure, existing and pipelined products, and key developments that are propelling the market growth.
Detailed Market Analysis:
The Sepsis Diagnostics market study also includes SWOT analysis, the profiles of disease management companies, and market strategies. In addition, the study focuses on company profiles, leading industry players with information such as services and products offered with financial data of the last 3 years, and insights on the progress in the past five years. The study aims to offer a synopsis of the global market with comprehensive market segmentation by deployment, component, end-user, and geography.
Market Breakdown
The Global Sepsis Diagnostics Market can be segmented By Technology (Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers), By Product (Blood Culture Media, Instruments), By Method (Automated), By Test Type (Lab, POC), By Pathogen (Bacterial, Fungal),By End-User (Hospitals, Pathology & Reference Laboratories) The historic backdrop for the market of Sepsis Diagnostics has been analyzed in tandem with gradual and recent developments to offer precise estimation of the market size.
Get ToC for the overview of the premium report @ https://www.quincemarketinsights.com/request-toc-59320?utm_source=tdc/ly
Regional Assessment:
In addition, the study covers regional segmentation that concentrates primarily on projected and current demand for the Sepsis Diagnostics market in Western Europe, North America, Eastern Europe, Asia Pacific, Middle East, and Rest of the World. The Study further focuses on the demand in individual application segments and in all regions.
Important Market Players:
The Sepsis Diagnostics market study concentrates on prominent industry players with figures and data, along with insights on business profiles, financial information of the last 3 years, products and services offered by the establishments, and key developments in the past five years. The study provides significant data on the market status of the prominent market players and offers opportunities and key trends in the market.
The major Sepsis Diagnostics market producers include Luminex, Becton, Dickinson, Company, Roche Diagnostics, Danaher, Thermo Fisher Scientific, Bruker, Abbott Laboratories, Immunexpress, Response Biomedical Corp., Axis-Shield Diagnostics.
Industry Highlights
The Sepsis Diagnostics market study examines the factors that are influencing the market from both supply-side and demand and further assesses market dynamics affecting the market over the forecast period, i.e., restraints, drivers, opportunities, and future trends. The Sepsis Diagnostics market study also offers a thorough PEST analysis for all the five regions, evaluating social, political, economic, and technological aspects affecting the market in these regions.
If You Have Any Query, Ask Our Experts @ https://www.quincemarketinsights.com/ enquiry-before-buying/enquiry-before-buying-59320?utm_source=tdc/ly
About Us:
We have market research intelligence capabilities to cater to clients’ requirements. We provide studies from nearly all major publications and extensively update our list frequently to offer you immediate online access to the world’s most up-to-date collection of expert analysis for companies, global markets, goods, and growth patterns.
Contact Us:
Quince Market Insights
Office No- A109,
Pune, Maharashtra 411028
Phone: APAC +91 706 672 4848 / US +1 208 405 2835 / UK +44 1444 39 0986
Email:[email protected]
Web: www.quincemarketinsights.com
“
Region : Global | Format: PDF | Report ID: FBI101443
The global in vitro diagnostics market size was valued at USD 61.22 billion in 2018 is projected to reach USD 87.11 billion by 2026, exhibiting a CAGR of 4.5% during the forecast period.
We are in process of revamping In-vitro Diagnostics (IVD) Market with respect to COVID-19 Impact.
Request SampleIVD are medical devices and accessories used to perform tests with the help of samples such as blood, urine, and tissue to help detect infection, prevent disease, monitor drug therapies and diagnose a medical condition.
In vitro diagnostics industry is consolidated in nature and demonstrates increasing adoption rates of diagnostic devices along with use of IVD instruments in clinical laboratories and hospitals. The industry has perceived significant developments over the recent years. Introduction of new techniques for rapid and fast disease diagnosis are anticipated to surge the demand for in vitro diagnostic services, subsequently, driving business growth during the forecast period.
The market is anticipated to witness the growth owing to technological advancements in healthcare, improved and efficient diagnostic tools, and increased availability of over the counter tests. Increasing demand for advanced, personalized and rapid diagnostic system is anticipated to propel the market.
Additionally, increased funding by government and other organizations in the healthcare sector is one of the factors likely to boost the global market during the forecast period. Various initiatives undertaken by the government to provide information and education on personalized medicine and IVD tools for effective patient management is anticipated to drive the in vitro diagnostics market growth.
MARKET DRIVERS
Request a Free sample to learn more about this report.
“Rising Prevalence of Chronic and Infectious Diseases to propel the Global Market.”
The rising prevalence of infectious diseases, leading to increasing demand for disease diagnosis is one of the factors anticipated to propel the market growth. According to the National Institute of Health (NIH), in 2017, around 23.5 million cases of autoimmune diseases were reported in America and this is expected to increase in the forthcoming years.
Additionally, increasing prevalence of cardiovascular diseases in developed and developing countries is one of the major factor driving the growth of the in vitro diagnosis. For instance, according to U.S. Department of Health & Human Services, around 735,000 Americans suffer from a heart attack every year. Additionally, as per the Heart Disease and Stroke Statistics, 2019 Update from the American Heart Association, around 116.4 million, or 46% of the US adults are estimated to have hypertension. The increasing number of patients suffering from cardiovascular diseases is likely to increase the demand for the in vitro diagnostics tools, subsequently propelling market growth.
The rising consumption of tobacco and alcohol, adoption of a sedentary lifestyle, unhealthy dietary habits, etc. are the major factors responsible for increasing prevalence of chronic diseases. The rising prevalence of the chronic disorders is likely to increase the demand of the in vitro testing.
“Increasing Use of Point-of-care (POC) and Technological Advancements in IVD Tools to Drive the In Vitro Diagnostics Market.”
Increasing adoption and demand for point-of-care (POC) devices is expected to fuel market growth. Additionally, the introduction of advanced technologies, such as biochips and nano-biotechnology, and miniaturization of microfluidic tools is likely to boost the demand for point-of-care (POC) devices. These advanced techniques have facilitated easy access to point-of-care diagnostic tests and offer quick and valid test results, thereby fueling the demand for in vitro diagnostic instruments . These factors are subsequently anticipated to drive the growth of the market during the forecast period.
For instance, In June 2019, Abbott launched, Afinion HbA1c Dx assay, its first rapid point-of-care test for diagnosis of diabetes among general population. The increased investment by key market players in the development of technologically advanced and rapid testing devices is likely to drive the growth of the market.
Recently, adoption of rapid and accurate tests for diagnosis of infectious diseases and other chronic diseases is driving the market. In March 2018, Sekisui Diagnostics announced the launch of Silaris point-of-care (POC) for the diagnosis of infectious diseases. Such product launches will shift the patient preference from traditional diagnostic tools towards advanced IVD services.
SEGMENTATION
By Product Type Analysis
“Reagents & Consumables Segment to Generate the Highest Revenue”
As with the help of advanced technologies and rapid diagnosis, the in vitro diagnostics market is anticipated to grow at a faster rate. Increasing prevalence of chronic and infectious diseases, is projected to fuel the demand for diagnostics tools, that is projected to drive the growth of the market.
Reagents and consumables segment dominated the product type owing to their high usage in the in vitro diagnosis. Increased number of research and development activities for the diagnosis of chronic diseases is one of the major factor fueling the demand for reagents and consumables.
Rising demand and adoption of the self-test and point-of-care devices will subsequently increase the demand for these products. An increasing number of IVD tests is one of the major factors driving the growth of the reagents and consumables segment.
The instruments segment is expected to grow at a slower pace. Technologically advanced instruments and introduction of rapid testing tools are some of the factors propelling the segment growth. For instance, in April 2018, Altona Diagnostics GmbH, launched a CE-IVD marked AltoStar Molecular Diagnostics Workflow. It is a flexible and efficient automatic system that automates the entire workflow from sample preparation up to analysis.
By Application Analysis
“Oncology to Exhibit a Significant CAGR During the Forecast Period.”
Infectious diseases dominated the application segment and is anticipated to exhibit lucrative growth over the forecast period. Rising prevalence of cardiovascular diseases such as coronary artery disease, arrhythmias, and stroke globally is likely to increase the demand for IVD tools. These factors are expected to drive the growth of the cardiology segment subsequently, which will boost the in vitro diagnostics market.
Oncology segment held a substantial share and is projected to witness significant CAGR during the forecast period. Availability of advanced home care kits such as fecal occult blood test (FOBT) for diagnosis of colon cancer in homecare settings is one of the major factors likely to drive this segment.
The increasing prevalence of infectious disease and cancer are major factors boosting the demand for in vitro diagnosis. Increasing investment by research institutes and key market players in the development of the rapid and easy in vitro testing tools in the oncology is one of the major factor propelling the growth of the oncology segment.
By Technique
Drivers Roche Diagnostics Login
“Immunodiagnostics to hold a Leading Position in the Market”
The various techniques used in IVD are immunodiagnostics, clinical chemistry, molecular diagnostics, point-of-care, hematology, and others. The immunodiagnostics segment accounted for the largest share in the market.
Rising prevalence of chronic and infectious diseases and rising need for early diagnosis are some of the primary key factors attributed to the growth of the technique segment. Molecular diagnostics is expected to grow at a significant CAGR during the forecast period. This technology facilitates early detection of cancer, infectious diseases, and genetic disorders by using genetic technologies that helps in the detection of abnormalities in the prenatal stage.
Clinical chemistry segment accounted for the second-largest share in the technique segment. Attributing to various applications of clinical chemistry, including detection of hormone fluctuations and blood glucose levels is anticipated to propel the segment growth. Point of care segment is anticipated to grow at a significant CAGR during the forecast period owing to increased demand for the point of care testing diagnosis. The demand for rapid and accurate diagnosis globally is one of the major factor likely to accelerate the segment growth.
By End User Analysis
To know how our report can help streamline your business, Speak to Analyst
“Clinical Laboratories to Hold the Highest Share.”
Followed by clinical laboratories, hospitals are anticipated to hold the second-highest global market share. High demand for IVD tests as a result of increased in hospitalization is one of the factors propelling their use in the hospital segment.
Increasing demand for biosensors, pregnancy kits, and glucose meters to ensure quick and accurate results are some of the major factors propelling the growth of the physician's offices segment at a faster rate.
Increasing incidence of cardiac diseases and diabetes and the rising prevalence of infectious diseases in developing countries are the major factors driving the demand for point-of-care tests. The growing use of point of care devices within hospitals and physician’s office, especially in remote and rural areas, is also fueling the demand for point of care tests and subsequently driving the growth of the hospitals and physicians office segments.
Drivers Roche Diagnostics
REGIONAL ANALYSIS
North America In-vitro Diagnostics Market Size, 2018
To get more information on the regional analysis of this market, Request a Free sample
North America generated a revenue of USD 23.09 billion in 2018 and is anticipated to emerge dominant in the global in vitro diagnostics market during the forecast period. Adequate and favorable government regulations, well-established diagnostic infrastructure, adoption of technologically advanced diagnostic techniques, and presence of prominent key market players in this region are some of the significant factors anticipated the drive the market in North America.
Asia Pacific is expected to grow at a significant CAGR during the forecast period. Increasing prevalence of cardiovascular diseases and infectious diseases and rapid development in the healthcare infrastructure of developing countries such as India and China is anticipated to rise the demand for the IVD tools. These factors are expected to subsequently drive the market growth in the Asia Pacific at a faster pace.
On the other hand, Europe is projected to witness significant growth in the global market. The high-income countries, including Germany U.K., and Spain, are anticipated to contribute to the growth of this market in the region. Rising healthcare expenditure and increasing adoption of POC testing devices are some of the major factors driving the growth of the market in Europe.
The Middle East and Africa is anticipated to register high growth in the market owing to the technological developments, rapidly expanding hospital infrastructure, and entry of global players in the region through direct and indirect presence. The region is significantly heading towards the modernization and technological developments. Latin America is also expected to grow at a significant CAGR during the forecast period.
INDUSTRY KEY PLAYERS
“F. Hoffmann-La Roche Ltd,Abbott Laboratories, Thermo Fischer Scientific Inc., and Siemens Hold Dominant Shares by Providing IVD Tools ”
The top key market players focus on strategies, such as mergers and acquisitions, collaborations, and new product developments and launches to strengthen their market position globally and increase their market share. For instance, in August 2018, Sysmex Corp. and JVCKENWOOD Corp. jointly established a new manufacturing company “Creative Nanosystems Corp.” to develop and manufacture bio-devices. These strategic collaborations strengthened the company’s product portfolio and reinforced its market position.
Siemens Healthcare is one of the most significant market players in the healthcare industry and major player in laboratory diagnostics, medical information technology, and medical imaging. The diagnostics division of the company includes products for clinical chemistry, drug testing, hematology, coagulation, immunoassay, infectious diseases, molecular diagnosis, point of care testing and many others. Having a strong product portfolio and supply chain makes the company dominant in the market. Siemens Healthcare, Abbott Laboratories, F. Hoffmann-La Roche Ltd, and Thermo Fischer Scientific Inc., hold a dominant market share by providing a wide range of tools for the disease detection and analysis.
IN VITRO DIAGNOSTICS MARKET COMPANIES:
- Abbott Laboratories
- Siemens
- Thermo Fisher Scientific Inc.
- Danaher
- Bio-Rad Laboratories, Inc.
- QIAGEN
- Sysmex Corporation
- Quest Diagnostics Incorporated
- Other Prominent Players
REPORT COVERAGE
A growing trend observed in the penetration of the in vitro diagnostics market across the industries.
The report provides qualitative and quantitative insights on the global market and detailed analysis of market size & growth rate for all possible segments in the market. Along with this, the report provides an elaborative analysis of the global market dynamics and competitive landscape. Various key insights presented in the report are the price trend analysis, recent industry developments such as mergers & acquisitions, the reimbursement policies, SWOT analysis, and key retail industry trends, competitive landscape and company profiles.
To gain extensive insights into the market, Request for Customization
Report Scope & Segmentation
ATTRIBUTE | DETAILS |
Study Period | 2015-2026 |
Base Year | 2018 |
Forecast Period | 2019-2026 |
Historical Period | 2015-2017 |
Unit | Value (USD Million) |
Segmentation | By Product Type
|
By Technique
| |
By Application
| |
By End User
| |
By Geography
|
Frequently Asked Questions
Fortune Business Insights says that the in-vitro diagnostics market was valued at US$ 61.22 Bn in 2018 and is projected to reach US$ 87.11 Bn by 2026.
Growing at a CAGR of 4.5%, the in-vitro diagnostics market will exhibit steady growth in the forecast period (2019-2026)
Infectious disease in-vitro diagnostics segment is expected to be the leading segment in the in-vitro diagnostics market during the forecast period.
The rising prevalence of chronic and infectious diseases and the increasing use of point-of-care (POC) diagnostics and technological advancements in - vitro diagnostics tools are some of the factors anticipated to drive the growth of the in-vitro diagnostics market.
F. Hoffmann-La Roche Ltd, Abbott, Thermo Fischer Scientific Inc., and Siemens are the top players in the in-vitro diagnostics market.
North America is expected to hold the highest market share in the in-vitro diagnostics market.
The use of in-vitro diagnostics tools such as point of care testing tools at physicians’ offices and hospitals are some of the factors expected to drive the adoption of in-vitro diagnostics
Introduction technologically advanced, and rapid diagnostics kits and tools are one of the in-vitro diagnostics market trends.
Seeking Comprehensive Intelligence on Different Markets?
Get in Touch with Our Experts
Speak to an Expert